Pancreatic Cancer Research

ResearcherPeking University First HospitalActive in the last 2 years

Chong Du

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2105-3078; OpenAlex author ID A5022462605. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 8

  1. Disruption of Super-Enhancers in Activated Pancreatic Stellate Cells Facilitates Chemotherapy and Immunotherapy in Pancreatic Cancer. Co-author DOI 10.1002/advs.202308637↗
  2. A Targeted Octahedral DNA Nanostructure Co-delivers siME3 and Doxorubicin to Enhance Collateral Lethality in ME2-Deficient Pancreatic Cancer. Co-author DOI 10.1021/acs.nanolett.4c05123↗
  3. BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis. Co-author DOI 10.1016/j.canlet.2019.02.031↗
  4. Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer … Co-author DOI 10.1021/acsnano.8b01573↗
  5. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer. Co-author DOI 10.3892/or.2018.6178↗
  6. Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/jca.21347↗
  7. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling. Co-author DOI 10.1016/j.canlet.2017.05.006↗
  8. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/15384047.2016.1219814↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yazhou Wang · 2 shared papers, 2024 · strength 0.44
  2. Zhengkui Zhang · 6 shared papers, 2016–2019 · strength 0.44
  3. Feng Wang · 5 shared papers, 2016–2019 · strength 0.37
  4. Ling Ma · 5 shared papers, 2016–2019 · strength 0.37
  5. Yinmo Yang · 5 shared papers, 2016–2019 · strength 0.37
  6. Marko Kornmann · 5 shared papers, 2016–2019 · strength 0.37
  7. Huahu Guo · 4 shared papers, 2017–2019 · strength 0.31
  8. Xiaodong Tian · 4 shared papers, 2017–2019 · strength 0.30
  9. Yinmo Yang · 2 shared papers, 2018–2024 · strength 0.27
  10. Guangjun Nie · 2 shared papers, 2018–2024 · strength 0.27
  11. Zipeng Lu · 1 shared paper, 2024 · strength 0.24
  12. Kuirong Jiang · 1 shared paper, 2024 · strength 0.24
  13. Kai Chen · 1 shared paper, 2024 · strength 0.20
  14. Xiaodong Tian · 2 shared papers, 2016–2018 · strength 0.14
  15. Yazhou Wang · 1 shared paper, 2019 · strength 0.09
  16. Xiaoran Liu · 1 shared paper, 2017 · strength 0.07
  17. Xiao Zhao · 1 shared paper, 2018 · strength 0.07
  18. Yazhou Wang · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.